Business Description
TYK Medicines Inc
ISIN : CNE100006L34
Share Class Description:
HKSE:02410: Ordinary Shares - Class HDescription
TYK Medicines Inc is a drug discovery research and development centre. The company and its subsidiaries are principally engaged in the research, development and commercialization of pharmaceutical products.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.75 | |||||
| Equity-to-Asset | -1.56 | |||||
| Debt-to-Equity | -0.13 | |||||
| Debt-to-EBITDA | -0.59 | |||||
| Piotroski F-Score | N/A/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 38.93 | |||||
| 9-Day RSI | 58.32 | |||||
| 14-Day RSI | 67.78 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.19 | |||||
| Quick Ratio | 0.19 | |||||
| Cash Ratio | 0.15 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROA % | -36.96 | |||||
| ROIC % | -10.39 | |||||
| ROC (Joel Greenblatt) % | -109.07 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -45.3 | |||||
| EV-to-EBITDA | -46.91 | |||||
| EV-to-FCF | -94.66 | |||||
| Earnings Yield (Greenblatt) % | -2.21 | |||||
| FCF Yield % | -1 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
TYK Medicines Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil HK$) | |||
| EPS (TTM) (HK$) | -0.639 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 67.78 | ||
| 14-Day ATR (HK$) | 2.697786 | ||
| 20-Day SMA (HK$) | 26.9 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (HK$) | 12.86 - 34.35 | ||
| Shares Outstanding (Mil) | 370.84 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
TYK Medicines Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
TYK Medicines Inc Stock Events
| Event | Date | Price(HK$) | ||
|---|---|---|---|---|
| No Event Data | ||||
TYK Medicines Inc Frequently Asked Questions
What is TYK Medicines Inc(HKSE:02410)'s stock price today?
The current price of HKSE:02410 is HK$29.95. The 52 week high of HKSE:02410 is HK$34.35 and 52 week low is HK$12.86.
When is next earnings date of TYK Medicines Inc(HKSE:02410)?
The next earnings date of TYK Medicines Inc(HKSE:02410) is .
Does TYK Medicines Inc(HKSE:02410) pay dividends? If so, how much?
TYK Medicines Inc(HKSE:02410) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers